Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Over the last 30 years, diverse types of nano-sized drug delivery systems (nanoDDSs) have been intensively explored for cancer therapy, exploiting their passive tumor targetability with an enhanced permeability and retention effect. However, their systemic administration has aroused some unavoidable...
Main Authors: | Wan Su Yun, Jeongrae Kim, Dong-Kwon Lim, Dong-Hwee Kim, Seong Ik Jeon, Kwangmeyung Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/13/15/2225 |
Similar Items
-
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
by: Jeongrae Kim, et al.
Published: (2023-10-01) -
Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
by: Roman A. Verkhovskii, et al.
Published: (2023-05-01) -
Development of Injectable and Biodegradable Needle-Type Starch Implant for Effective Intratumoral Drug Delivery and Distribution
by: Lee C
Published: (2022-09-01) -
The crosstalk of intratumor bacteria and the tumor
by: Jiating Huang, et al.
Published: (2024-01-01) -
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
by: Ester Blanco, et al.
Published: (2023-01-01)